KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Total Debt (2016 - 2025)

Historic Total Debt for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $54.6 billion.

  • Amgen's Total Debt fell 914.32% to $54.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $54.6 billion, marking a year-over-year decrease of 914.32%. This contributed to the annual value of $54.6 billion for FY2025, which is 914.32% down from last year.
  • Latest data reveals that Amgen reported Total Debt of $54.6 billion as of Q4 2025, which was down 914.32% from $54.6 billion recorded in Q3 2025.
  • Over the past 5 years, Amgen's Total Debt peaked at $64.6 billion during Q4 2023, and registered a low of $32.7 billion during Q1 2021.
  • In the last 5 years, Amgen's Total Debt had a median value of $55.4 billion in 2025 and averaged $50.3 billion.
  • Its Total Debt has fluctuated over the past 5 years, first soared by 6851.21% in 2023, then plummeted by 1037.02% in 2025.
  • Quarter analysis of 5 years shows Amgen's Total Debt stood at $33.3 billion in 2021, then increased by 16.92% to $38.9 billion in 2022, then surged by 65.91% to $64.6 billion in 2023, then dropped by 6.99% to $60.1 billion in 2024, then dropped by 9.14% to $54.6 billion in 2025.
  • Its Total Debt stands at $54.6 billion for Q4 2025, versus $54.6 billion for Q3 2025 and $56.2 billion for Q2 2025.